Member Info for Jarv55

Great news well done all
19 October 2020

Remote Monitored Systems plc

("Remote Monitored Systems", "RMS", the "Company" or the "Group")

Update on Acquisition of Pharm 2 Farm

Publication of Circular and Notice of General Meeting

On 21 August 2020, the Company announced that it had signed a binding Share Purchase Agreement for the acquisition of 100% of the share capital of Pharm2Farm Limited ("P2F") (the "Acquisition"). Completion of the Acquisition is subject to regulatory and RMS shareholder approval. The Acquisition will be satisfied by the issue of 600,000,000 new ordinary shares of 0.01 pence each in the capital of the Company ("Consideration Shares"), equating to approximately £2,370,000 based on RMS's closing share price on 20 August 2020.

RMS is pleased to announce a shareholder circular (the "Circular") will be published today that contains information on the background to, and reasons for, the Acquisition and includes a notice convening a general meeting of the Company (the "General Meeting"). The General Meeting will be held at 10:30 a.m. on 4 November 2020 at GyroMetric Systems Limited, Unit 23, The Heathcoat Building, Nottingham Science and Technology Park, University Boulevard, Nottingham, NG7 2QJ. The Circular is expected to be posted to RMS Shareholders shortly.

Given the evolving situation regarding Covid-19 and the changing restrictions on social contact, public gatherings and non-essential travel, RMS Shareholders will not be permitted to attend the General Meeting in person, save for those RMS Shareholders permitted by the chairman of the meeting to attend to establish a quorum. Instead, shareholders should appoint the chairman of the meeting, rather than a third party, as their proxy by the relevant time. A copy of the Circular will be available for inspection on the Company's website at https://www.remotemonitoredsystems.com.

The Acquisition of P2F is expected to be completed on 5 November 2020, subject to satisfaction or (where applicable) waiver of the conditions, the outstanding condition being the passing of the resolutions at the General Meeting.

Unless otherwise indicated, all defined terms in this announcement shall have the same meaning as described in the Circular.

Once this breaks 0.78 1p should come quickly https://invst.ly/sie7u

Excellent presentation and one everyone should watch they are not giving away the farm
https://www.youtube.com/watch?v=g7nvORAcnJs&feature=youtu.be

https://twitter.com/confluencetradr/status/1317018136915435520

https://www.proactiveinvestors.co.uk/companies/news/931620/braveheart-investee-paraytec-completes-proof-of-concept-trials-for-coronavirus-test-931620.html

Great news at Brh this morning

Should do multiples from here in the next few months

I am sure the government will be interested in this needs all the tests it can get.

As announced on 5 October 2020, proof of concept was achieved for the Optical Detection System. Since then the focus of the Proof of Concept trials have has been on the Capture & Signal Generation Modules.

Braveheart is now pleased to confirm that Proof of Concept has now been achieved for the Capture & Signal Generation Modules, which successfully completes the Proof of Concept trials. The directors of Braveheart believe that this test will be the first to combine a rapid result with very high detection sensitivity. Work will now turn toward the acquisition of clinically relevant data, to facilitate optimisation of the functional capabilities of the test, together with a programme of product refinement and development. Meanwhile, regulatory approval for live virus trials and the acquisition of clinical data is being sought.

Fantastic result well done all those that held.

no trumpton

Expect to see some US buyers coming in and taking the shares off the bedwetters here.

Dacorum the book has already been built what does that tell you?

This isn't most placings the revenue could be huge here and the ii's know it, investors know it derampers don't have a clue how big this could be.
SNG001 is the most successful antiviral drug in trials, the placing has been taken by the yanks, (what do they know)? Numis involved, it’s going to phase 3 clinical trials in 20 countries USA being one of them where EUA FDA will be needed! FDA approvals are due and they need that to EUA in USA for phase 3 Also, this drug can be self administered from home as its non intravenous; ready for the big lockdown freeze over the next 4 months where sentiment will follow... they have over 70m ready to go.

I think its silly to sell here especially as it was oversubscribed means those brokers that want in have to buy open market

The Company has placed, in aggregate, 45,714,285 Placing Shares at the Issue Price of 175 pence per share with existing and new institutional and other shareholders.
New ii's Us investors maybe

fund a Phase III clinical trial of SNG001 in c. 900 COVID-19 patients across c. 20 countries, with an anticipated start date in Q4 2020;

20 COUNTRIES!!!!

Think what is current right now. Think outside the box before you hit that sell button what if the Yanks took most of that placing?

Anyone who is switched on will not panic they will buy any dip that rns is huge progress.

Watch the iis come on board this is another Ncyt in the making.